Premenstrual Dysphoric Disorder in East Asia: A Review of the Literature

Schatz, David Beck; Hsiao, Mei‐Chun; Liu, Chia-Yih

doi:10.2190/pm.43.4.f

“…15 The rate of PMDD in East Asia including Japan, Korea, China, Taiwan, Hong Kong, and Macau per a recent literature review was 1.3% to 2.8%. 16 Rates are estimated to be somewhat higher in Latin America, 17 with one cohort of Brazilian women demonstrating a prevalence of 17.6% for PMDD. 18 Morbidity of severe PMS is significant, with functional impairment similar to other depressive disorders.…”

Section: Epidemiology and Morbiditymentioning

confidence: 99%

Management of Premenstrual Dysphoric Disorder: A Scoping Review

Carlini,

Lanza di Scalea,

McNally

et al. 2024

FOC

0

View full text Add to dashboard Cite

Premenstrual dysphoric disorder (PMDD) and premenstrual syndrome (PMS) refer to physical, cognitive, or affective symptoms that arise in the late luteal phase and remit with menses. The present work is a clinically focused scoping review of the last twenty years of research on treatment for these disorders. A search of key terms using the PubMed/Medline, the Cochrane Library, Embase, and Web of Science databases was performed, and 194 studies of adult women met initial inclusion criteria for review. Research studies concerning medications, pharmacological and non-pharmacological complementary and alternative medicine treatments, and surgical interventions with the most available evidence were appraised and summarized. The most high-quality evidence can be found for the use of selective serotonin reuptake inhibitors (SSRIs) and combined oral contraceptives (COCs), with gonadotropin releasing hormone (GnRH) agonists and surgical interventions showing efficacy for refractory cases. While there is some evidence of the efficacy of alternative and complementary medicine treatments such as nutraceuticals, acupuncture, and yoga, variability in quality and methods of studies must be taken into account.

show abstract

“…15 The rate of PMDD in East Asia including Japan, Korea, China, Taiwan, Hong Kong, and Macau per a recent literature review was 1.3% to 2.8%. 16 Rates are estimated to be somewhat higher in Latin America, 17 with one cohort of Brazilian women demonstrating a prevalence of 17.6% for PMDD. 18 Morbidity of severe PMS is significant, with functional impairment similar to other depressive disorders.…”

Section: Epidemiology and Morbiditymentioning

confidence: 99%

Management of Premenstrual Dysphoric Disorder: A Scoping Review

Carlini¹,

Scalea²,

McNally³

et al. 2022

IJWH

View full text Add to dashboard Cite

Premenstrual dysphoric disorder (PMDD) and premenstrual syndrome (PMS) refer to physical, cognitive, or affective symptoms that arise in the late luteal phase and remit with menses. The present work is a clinically focused scoping review of the last twenty years of research on treatment for these disorders. A search of key terms using the PubMed/Medline, the Cochrane Library, Embase, and Web of Science databases was performed, and 194 studies of adult women met initial inclusion criteria for review. Research studies concerning medications, pharmacological and non-pharmacological complementary and alternative medicine treatments, and surgical interventions with the most available evidence were appraised and summarized. The most high-quality evidence can be found for the use of selective serotonin reuptake inhibitors (SSRIs) and combined oral contraceptives (COCs), with gonadotropin releasing hormone (GnRH) agonists and surgical interventions showing efficacy for refractory cases. While there is some evidence of the efficacy of alternative and complementary medicine treatments such as nutraceuticals, acupuncture, and yoga, variability in quality and methods of studies must be taken into account.

show abstract

“…This illness has been recently designated as a disorder in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) (http://www.dsm5.org/Pages/Default.aspx). Prevalence of premenstrual dysphoric disorder varies from 1.3% to 8% [18, 19]. Symptoms of this disorder significantly impair daily functioning [20, 21], and its etiology is unclear [16, 18, 20].…”

Section: Introductionmentioning

confidence: 99%

Toxoplasma gondiiInfection and Premenstrual Dysphoric Disorder: A Cross-Sectional Study

Alvarado‐Esquivel

¹

,

Sánchez‐Anguiano

²

,

Hernández‐Tinoco

³

et al. 2016

View full text Add to dashboard Cite

BackgroundPremenstrual dysphoric disorder is a severe form of premenstrual syndrome. The influence of Toxoplasma gondii (T. gondii) infection on clinical features in women with this disorder has not been studied. Therefore, we determined the association of T. gondii infection with symptoms and signs in women suffering from premenstrual dysphoric disorder.MethodsWe performed a cross-sectional study of 151 women suffering from premenstrual dysphoric disorder. Anti-Toxoplasma IgG and IgM antibodies were detected in sera of the participants using enzyme-linked immunoassays (EIAs). In addition, T. gondii DNA was detected in whole blood of IgG seropositive participants using polymerase chain reaction. We obtained the clinical data of women with the aid of a questionnaire. The association of T. gondii infection with clinical characteristics of women was assessed by bivariate and multivariate analyses.ResultsAnti-T. gondii IgG antibodies were found in 10 (6.6%) of the 151 women studied. Of the 10 IgG seropositive women, four (40.0%) were positive for anti-T. gondii IgM antibodies, and one (10.0%) for T. gondii DNA. Mean number (25.8 ± 7.58) of premenstrual clinical characteristics in seropositive women was similar to that (29.22 ± 9.13) found in seronegative women (P = 0.25). Logistic regression showed that seropositivity to T. gondii was negatively associated with difficulty concentrating (OR: 0.18; 95% CI: 0.03 - 0.91; P = 0.03), and positively associated with out of control feeling or overwhelmed (OR: 9.00; 95% CI: 1.32 - 62.00; P = 0.02).ConclusionsResults of this first study on the association of T. gondii infection and clinical characteristics of premenstrual dysphoric disorder suggest that this infection might be linked to some symptoms of this disorder. We report for the first time the association of T. gondii infection and out of control feeling or overwhelmed. Results warrant for further research on the role of T. gondii in premenstrual dysphoric disorder.

show abstract

Premenstrual Dysphoric Disorder in East Asia: A Review of the Literature

Abstract: The rates of PMDD appear to be lower in East Asia, though reasons for this result are discussed. Few studies have been conducted examining the efficacy of psychotropic medications commonly used to treat PMDD in this population.

Cited by 9 publications

References 34 publications

Management of Premenstrual Dysphoric Disorder: A Scoping Review

Management of Premenstrual Dysphoric Disorder: A Scoping Review

Management of Premenstrual Dysphoric Disorder: A Scoping Review

Toxoplasma gondiiInfection and Premenstrual Dysphoric Disorder: A Cross-Sectional Study

Contact Info

Product

Resources

About